The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin
Crossref DOI link: https://doi.org/10.1186/s12933-018-0704-1
Published Online: 2018-04-18
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Aroor, Annayya R.
Manrique-Acevedo, Camila
DeMarco, Vincent G. http://orcid.org/0000-0003-2092-9995
Funding for this research was provided by:
Boehringer Ingelheim
Text and Data Mining valid from 2018-04-18
Article History
Received: 15 February 2018
Accepted: 12 April 2018
First Online: 18 April 2018